BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17092616)

  • 1. Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: a clinical and laboratory diagnostic dilemma.
    Decaro N; Desario C; Elia G; Campolo M; Lorusso A; Mari V; Martella V; Buonavoglia C
    Vaccine; 2007 Jan; 25(7):1161-6. PubMed ID: 17092616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Challenges in Canine Parvovirus 2c in Vaccine Failure Cases.
    Yip HYE; Peaston A; Woolford L; Khuu SJ; Wallace G; Kumar RS; Patel K; Ahani Azari A; Akbarzadeh M; Sharifian M; Amanollahi R; Jafari Jozani R; Khabiri A; Hemmatzadeh F
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MT-PCR panel detection of canine parvovirus (CPV-2): Vaccine and wild-type CPV-2 can be difficult to differentiate in canine diagnostic fecal samples.
    Meggiolaro MN; Ly A; Rysnik-Steck B; Silva C; Zhang J; Higgins DP; Muscatello G; Norris JM; Krockenberger M; Šlapeta J
    Mol Cell Probes; 2017 Jun; 33():20-23. PubMed ID: 28254505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
    Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
    Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are vaccine strain, type or administration protocol risk factors for canine parvovirus vaccine failure?
    Altman KD; Kelman M; Ward MP
    Vet Microbiol; 2017 Oct; 210():8-16. PubMed ID: 29103701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b).
    Pratelli A; Cavalli A; Normanno G; De Palma MG; Pastorelli G; Martella V; Buonavoglia C
    J Vet Med B Infect Dis Vet Public Health; 2000 May; 47(4):273-6. PubMed ID: 10861195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of DNA from canine parvovirus modified-live virus in canine tissues.
    Schirò G; Mira F; Decaro N; Desario C; Chiaramonte G; Di Bella S; Cannella V; Purpari G; Ventriglia G; Randazzo V; Vicari D; Gucciardi F; Castronovo C; Guercio A
    Vet Res Commun; 2023 Jun; 47(2):567-574. PubMed ID: 36323836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.
    Decaro N; Desario C; Elia G; Martella V; Mari V; Lavazza A; Nardi M; Buonavoglia C
    New Microbiol; 2008 Jan; 31(1):125-30. PubMed ID: 18437851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term viremia and fecal shedding in pups after modified-live canine parvovirus vaccination.
    Decaro N; Crescenzo G; Desario C; Cavalli A; Losurdo M; Colaianni ML; Ventrella G; Rizzi S; Aulicino S; Lucente MS; Buonavoglia C
    Vaccine; 2014 Jun; 32(30):3850-3. PubMed ID: 24793948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine parvovirus in vaccinated dogs: a field study.
    Miranda C; Thompson G
    Vet Rec; 2016 Apr; 178(16):397. PubMed ID: 26960988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of modified live canine parvovirus type 2b induces systemic immune response.
    Cavalli A; Desario C; Marinaro M; Losurdo M; Camero M; Decaro N; Catella C; Lanave G; Buonavoglia C
    Vaccine; 2020 Jan; 38(2):115-118. PubMed ID: 31628031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
    Siedek EM; Schmidt H; Sture GH; Raue R
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
    Buonavoglia C; Cavalli A; Gravino E; Voigt V; Buonavoglia D; de Caprariis D
    Zentralbl Veterinarmed B; 1994 Mar; 41(1):3-8. PubMed ID: 7941844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
    Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
    New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic tools based on minor groove binder probe technology for rapid identification of vaccinal and field strains of canine parvovirus type 2b.
    Decaro N; Martella V; Elia G; Desario C; Campolo M; Buonavoglia D; Bellacicco AL; Tempesta M; Buonavoglia C
    J Virol Methods; 2006 Dec; 138(1-2):10-6. PubMed ID: 16911835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of canine parvovirus (CPV) strains detected in vaccinated puppies in Brazil.
    Castro TX; Costa EM; Leite JP; Labarthe NV; Cubel Garcia RC
    Res Vet Sci; 2011 Apr; 90(2):336-40. PubMed ID: 20609453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual "Asian-origin" 2c to 2b point mutant canine parvovirus (Parvoviridae) and canine astrovirus (Astroviridae) co-infection detected in vaccinated dogs with an outbreak of severe haemorrhagic gastroenteritis with high mortality rate in Hungary.
    Boros Á; Albert M; Urbán P; Herczeg R; Gáspár G; Balázs B; Cságola A; Pankovics P; Gyenesei A; Reuter G
    Vet Res Commun; 2022 Dec; 46(4):1355-1361. PubMed ID: 36129562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of canine parvovirus types 2b and 2c in canine faecal samples contaminating urban thoroughfares in Brazil.
    Gogone ICVP; de Barros FRO; Possatti F; Alfieri AA; Takiuchi E
    Can J Microbiol; 2020 Feb; 66(2):138-143. PubMed ID: 31714839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controlled clinical trials.
    Hernández-Blanco B; Catala-López F
    Vet Microbiol; 2015 Oct; 180(1-2):1-9. PubMed ID: 26249827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.